Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2014 1
2015 1
2016 2
2017 9
2018 2
2019 1
2020 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year
Filters applied: . Clear all
Page 1
Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer.
Terranova-Barberio M, Pawlowska N, Dhawan M, Moasser M, Chien AJ, Melisko ME, Rugo H, Rahimi R, Deal T, Daud A, Rosenblum MD, Thomas S, Munster PN. Terranova-Barberio M, et al. Among authors: pawlowska n. Nat Commun. 2020 Jul 17;11(1):3584. doi: 10.1038/s41467-020-17414-y. Nat Commun. 2020. PMID: 32681091 Free PMC article. Clinical Trial.
HDAC inhibition potentiates immunotherapy in triple negative breast cancer.
Terranova-Barberio M, Thomas S, Ali N, Pawlowska N, Park J, Krings G, Rosenblum MD, Budillon A, Munster PN. Terranova-Barberio M, et al. Among authors: pawlowska n. Oncotarget. 2017 Dec 12;8(69):114156-114172. doi: 10.18632/oncotarget.23169. eCollection 2017 Dec 26. Oncotarget. 2017. PMID: 29371976 Free PMC article.
Histone Deacetylase Inhibition with Panobinostat Combined with Intensive Induction Chemotherapy in Older Patients with Acute Myeloid Leukemia: Phase I Study Results.
Wieduwilt MJ, Pawlowska N, Thomas S, Olin R, Logan AC, Damon LE, Martin T, Kang M, Sayre PH, Boyer W, Gaensler KML, Anderson K, Munster PN, Andreadis C. Wieduwilt MJ, et al. Among authors: pawlowska n. Clin Cancer Res. 2019 Aug 15;25(16):4917-4923. doi: 10.1158/1078-0432.CCR-19-0171. Epub 2019 May 31. Clin Cancer Res. 2019. PMID: 31152020 Free article. Clinical Trial.
Synthesis and antimicrobial activity of chiral quaternary N-spiro ammonium bromides with 3',4'-dihydro-1'H-spiro[isoindoline-2,2'-isoquinoline] skeleton.
Bielawski K, Leszczyńska K, Kałuża Z, Bielawska A, Michalak O, Daniluk T, Staszewska-Krajewska O, Czajkowska A, Pawłowska N, Gornowicz A. Bielawski K, et al. Among authors: pawlowska n. Drug Des Devel Ther. 2017 Jul 5;11:2015-2028. doi: 10.2147/DDDT.S133250. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28740363 Free PMC article.
Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors.
Bartelink IH, Prideaux B, Krings G, Wilmes L, Lee PRE, Bo P, Hann B, Coppé JP, Heditsian D, Swigart-Brown L, Jones EF, Magnitsky S, Keizer RJ, de Vries N, Rosing H, Pawlowska N, Thomas S, Dhawan M, Aggarwal R, Munster PN, Esserman LJ, Ruan W, Wu AHB, Yee D, Dartois V, Savic RM, Wolf DM, van 't Veer L. Bartelink IH, et al. Among authors: pawlowska n. Breast Cancer Res. 2017 Sep 11;19(1):107. doi: 10.1186/s13058-017-0896-4. Breast Cancer Res. 2017. PMID: 28893315 Free PMC article.
'Toy' laser macular burns in children: 12-month update.
Raoof N, O'Hagan J, Pawlowska N, Quhill F. Raoof N, et al. Among authors: pawlowska n. Eye (Lond). 2016 Mar;30(3):492-6. doi: 10.1038/eye.2015.222. Epub 2015 Nov 27. Eye (Lond). 2016. PMID: 26611842 Free PMC article.
18 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page